The Right Treatment for the Right Patient – Personalised Treatment of Breast Cancer
暂无分享,去创建一个
T. Kühn | A. Scharl | A. Salterberg | T. Papathemelis | A Scharl | T Kühn | T Papathemelis | A Salterberg
[1] Z. Hall. Cancer , 1906, The Hospital.
[2] J. Westman. The right to treatment. , 1977, Journal of autism and childhood schizophrenia.
[3] D. Wallwiener,et al. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. , 1998, The New England journal of medicine.
[4] S. Dobie,et al. Prophylactic mastectomy for prevention of breast cancer. , 1999, The Journal of family practice.
[5] G. Kundt,et al. Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. , 2003, Breast cancer research and treatment.
[6] L. Fallowfield,et al. Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments? , 2001, Breast Cancer Research and Treatment.
[7] Robert M Elashoff,et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.
[8] M. Morrow,et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Peto,et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. , 2010, Journal of the National Cancer Institute. Monographs.
[10] M. Beckmann,et al. The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer , 2010, Breast Care.
[11] Dawn L. Hershman,et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer , 2011, Breast Cancer Research and Treatment.
[12] Early Breast Cancer Trialists' Collaborative Group. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[13] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.
[14] T. Julian,et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.
[15] L. Ngo,et al. Causes of death and relative survival of older women after a breast cancer diagnosis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. R. del Turco,et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. , 2012, European journal of cancer.
[17] Thomas J. Smith,et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Cutter,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials , 2012, The Lancet.
[19] M. Brennan,et al. Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer. , 2012, Breast.
[20] R. Peto,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. , 2012, Lancet.
[21] Barbara L. Smith,et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Morrow,et al. Effect of Margin Width on Local Recurrence in Triple-Negative Breast Cancer Patients Treated with Breast-Conserving Therapy , 2014, Annals of Surgical Oncology.
[23] K. Kostev,et al. Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis , 2013, Breast Cancer Research and Treatment.
[24] R. Chlebowski. Nutrition and physical activity influence on breast cancer incidence and outcome. , 2013, Breast.
[25] P. Goodwin. Obesity and endocrine therapy: host factors and breast cancer outcome. , 2013, Breast.
[26] R. Turner,et al. Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes , 2013, Annals of surgery.
[27] A. Scharl,et al. Multimodale Therapie des nicht metastasierten Mammakarzinoms , 2014, Der Onkologe.
[28] M. Rezai,et al. Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto. , 2014 .
[29] S. Gomez,et al. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. , 2014, JAMA.
[30] Seema A Khan,et al. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer , 2014, Annals of Surgical Oncology.
[31] J. Cuzick,et al. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.
[32] David A. Williams,et al. Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy , 2014, Cancer.
[33] A. Giobbie-Hurder,et al. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. , 2014, The New England journal of medicine.
[34] L. Turnbull,et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] A. Giobbie-Hurder,et al. Adjuvant ovarian suppression in premenopausal breast cancer. , 2015, The New England journal of medicine.
[36] B. Hutton,et al. Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer? , 2015, Journal of oncology practice.
[37] D. Cameron,et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. , 2015, The Lancet. Oncology.
[38] M. Ellis,et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. , 2015, The New England journal of medicine.
[39] Carsten Denkert,et al. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] C. Gross,et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.